Emanuel N Maisel Professor of Oncology; Director, University of Michigan Rogel Cancer Center; Associate Dean for Cancer Prevention
PhD, Johns Hopkins University
Fearon has authored more than 135 peer-reviewed research manuscripts and more than 60 review/editorial articles and book chapters. He has pursed research in the cancer genetics field, particularly investigations of selected gene defects that underlie colon and rectal tumor development and progression to advanced stages. He has served on the editorial boards of various journals in the cancer biology and human genetics fields and currently is an editorial board member or editor for a number of journals, including The Journal of Biological Chemistry, Current Biology, Journal of Clinical Investigation, Gastroenterology and Molecular Cancer Research. In addition, he has served as a member or chair of various National Institutes of Health and National Cancer Institute advisory groups and grant review committees, including the Panel to Investigate the NIH Investment in Gene Therapy, the National Cancer Institute Board of Scientific Advisors, and the NIH Pathology B and Cancer Genetics Study Sections.
Fearon’s honors include election to the American Society for Clinical Investigation (where he served as vice president, president-elect and president), the Association of American Physicians, the Johns Hopkins University Society of Scholars and the National Academy of Medicine. He is also a fellow of the American Association for the Advancement of Science.
Member Faculty Advisory Committee
Rogel Cancer Center
Community and Professional Affiliation(s)
American Society for Clinical Investigation | Association of American Physicians | Johns Hopkins University Society of Scholars | National Institutes of Health and National Cancer Institute
Genetics / Genomics / other OMICS
- Lymph Node Metastases in Colon Cancer are Polyclonal.
- High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
- Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse